CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (8) ; 104-107 ; DOI: 10.12208/j.ijcr.20240313.

The effects of Yangxue Qingnao Wan on hemorheological parameters, blood pressure variability, and neurological function in patients with circulatory ischemia and hypertension after treatment
养血清脑丸治疗后循环缺血合并高血压对患者血液流变学指标、血压变异性及神经功能的影响

作者: 官沛 *

雷州市中医医院 广东湛江

*通讯作者: 官沛,单位:雷州市中医医院 广东湛江;

发布时间: 2024-08-23 总浏览量: 33

摘要

目的 探究养血清脑丸治疗后循环缺血合并高血压对患者血液流变学指标、血压变异性及神经功能的影响。方法 选取2020年12月-2022年10月在我科收治的80例后循环缺血合并高血压患者,随机分为两组,对照组给予常规治疗,观察组给予养血清脑丸治疗,比较治疗后的血液流变学指标、血压变异性及神经功能。结果 观察组基底动脉、椎动脉血流速度及总有效率高于对照组,而舒张压和收缩压水平及血液流变学指标低于对照组(P<0.05)。结论 用养血清脑丸治疗后循环缺血合并高血压对患者血液流变学指标、血压变异性及神经功能的效果显著,改善了生活质量,值得推广。

关键词: 养血清脑丸;后循环缺血合并高血压;血液流变学指标、血压变异性及神经功能

Abstract

Objective: To investigate the effects of Yangxue Qingnao Wan on the hemorheological parameters, blood pressure variability, and neurological function of patients with circulatory ischemia and hypertension after treatment. Method: 80 patients with posterior circulation ischemia combined with hypertension admitted to our department from December 2020 to October 2022 were randomly divided into two groups. The control group received conventional treatment, while the observation group received Yangxue Qingnao Pill treatment. The hemorheological indicators, blood pressure variability, and neurological function after treatment were compared. Result: The blood flow velocity and total effective rate of the basal and vertebral arteries in the observation group were higher than those in the control group, while the levels of diastolic and systolic blood pressure and hemorheological indicators were lower than those in the control group (P<0.05).
Conclusion  : The use of Yangxue Qingnao Wan in the treatment of post circulatory ischemia combined with hypertension has significant effects on patients' hemorheological indicators, blood pressure variability, and neurological function, improving their quality of life and is worthy of promotion.

Key words: Yangxue Qingnao Pill; Post circulatory ischemia combined with hypertension; Blood rheology indicators, blood pressure variability, and neurological function

参考文献 References

[1] 刘露.养血清脑颗粒联合盐酸乐卡地平治疗后循环缺血合并高血压的临床研究[J].河北医药,2021,41(13):2033-2035+2039.

[2] 刘小倩,郭兰凯,张唯聪.养血清脑丸联合倍他司汀治疗后循环缺血性眩晕疗效观察及对血液流变学指标的影响[J].新中医,2023,55(10):23-26.

[3] 刘春霞.养血清脑丸与高压氧联合治疗颈性眩晕的近期疗效评估[J].山西医药杂志,2020,44(03):319-320.

[4] 袁志俊,李小刚,何晓英,等.天舒片治疗后循环缺血合并高血压患者的临床疗效及其对内皮细胞膜微粒表达的影响[J].实用心脑肺血管病杂志,2021,26(2):84-87.

[5] 李雪媛.强力定眩胶囊与针刺法联合治疗后循环缺血性眩晕合并高血压患者的效果观察及研究机制[J].中国医学创新,2020,17(3):147-150. 

[6] 王会磊,裴媛.中西医结合治疗后循环缺血性眩晕合并高血压临床观察[J].中国医药指南,2022,20(13):120-122,126. 

[7] 张志军,王宝亮,付利然,等."调营充络"法治疗椎-基底动脉迂曲合并后循环缺血性眩晕的临床疗效及对DHI评分、BAEP的影响[J].中医研究,2022,35(2):26-30.

[8] 杨丽娟,武佳芳.椎动脉发育不良与急性后循环缺血性脑卒中[J].中华老年心脑血管病杂志,2021,20(1):75-77. 

[9] 李玲,呼兴华.同型半胱胺酸与后循环缺血性眩晕合并软斑的相关性研究[J].延安大学学报(医学科学版),2020, 17(3):42-45.

[10] 沈慧,龚洁芹.超高龄后循环缺血性卒中患者的临床特点及其预后影响因素研究[J].现代诊断与治疗,2021, 27(16):3045-3046. 

[11] 张文召,殷明君,韩淑辉,等.后循环TIA与椎基底动脉血管形态特点研究[J].中国实用神经疾病杂志,2020, 16(6):39-41.

引用本文

官沛, 养血清脑丸治疗后循环缺血合并高血压对患者血液流变学指标、血压变异性及神经功能的影响[J]. 国际临床研究杂志, 2024; 8: (8) : 104-107.